Grason?Stadler, a provider of clinical audiometric systems, announced the release of a new AABR/OAE screener, the GSI NovusTM.
The GSI Novus is a hand-held, comprehensive newborn hearing screening instrument. The Novus features a touch screen display and intuitive software in a compact hardware design. The Novus may be configured with any combination of AABR, TEOAE, and DPOAE, which allows for seamless two-stage infant screening.
The Novus uses a fast rate ABR algorithm with the CE-Chirp stimulus. The CE-Chirp is designed to produce Wave V responses that are 1.5 to 2 times larger than traditional ABR stimuli, making CE-Chirp ideal for newborn screening, according to Grason-Stadler. With larger responses, test times may be reduced and more infants can be screened every day. Distortion Product Otoacoustic Emissions (DPOAE) and Transient Otoacoustic Emissions (TEOAE) protocols add the flexibility required for efficiency in newborn screening.
HearSIM data management software compliments the GSI Novus; patient names can be loaded into the Novus or which patients need additional testing can be determined with the intuitive database view. In addition to viewing, storing, and printing test results, it is possible to export data to XML or Hi-Track. Device settings such as screener names, security, and risk factors may be configured from HearSIM.